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LA-REIMS
§ Simple routine analysis & screening (<10 s) of the intact faecal metabolome
§ Correlating mass spectral patterns with signatures of metabolic abnormalities
§ Unravelling aberrant pathways preceding the progression to metabolic consequences of IR
Early risk indication of children destined to develop obesity-related chronic metabolic
diseases
TAILORED INTERVENTION
§ Stratification biomarkers of metabolic functioning towards




1 in 2 adults
1 in 3 children (6-11 years)
>50% remains so into adulthood
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Figure 1. The mutual reinforcement of 
obesity & IR (upper) Schematic overview of 
precursors and risk factors for long-term 
(cardio)metabolic complications
(lower) Mechanisms leading to IR
INSULIN RESISTANCE
§ Impacting healthy growth and
functionality prior to clinical
diagnosis
§ Initiating premise towards DMT2
§ Reversible




§ Anthropometric: BMI, %fat mass
§ Metabolic: HbA1C, SHBG, FPG, FPI
§ Gold standard: hyper-insulinemic
euglycemic clamp & OGTT
Expensive, invasive,
lack of sensitivity/specificity
(obesity = heterogeneous phenotype) &




























uptake of glucose 
Hepatic glucose production 
FAECAL FINGERPRINTING
The faecal metabolome enables a
functional readout of the symbiotic
intertwining of the host, gut microbiome
and environmental exposure.
PROOF OF CONCEPT
Gut metabolic phenotyping of
obese and healthy children




I. Gut metabolic fingerprints
II. Longitudinal follow-up 
(2 years)
X à x à x à x à X
III. Candidate biomarker 
discovery for 
prognosis & prevention of 






I. Faecal metabolic fingerprinting
II. Elucidating discriminative metabolites associated with 
IR and/or low-grade inflammation
III. Prognostic & predictive potential of plausible 
biomarkers








§ Opolette HE 2940
§ Rapid Evaporative Ionisation MS
Figure 2. OPLS-DA model following 
UHPLC-HRMS metabolic faecal 
fingerprinting (R2Y 0.996
Q2Y 0.902, P-value 6.9e-4)
Figure 3. Venn diagram1 displaying the number of features detected using 









§ R Software Version 3.5.3
§ MetaboAnalyst 4.0 (pathway &
ROC curve analysis, …)
Biomarker Annotation
§ Human Metabolome Database,
LIPID MAPS® OGTT
SHBG, FPG, FPI, FFA,
hs-CRP, leptin & adiponectin
STUDY DESIGN
1De Paepe E., et al., Anal. Chim. Acta,1033:108–118.
Weight, length, gestational, 










BMI z-score > 1.3
N= 120
